A plasmid-encoded peptide from Staphylococcus aureus induces anti-myeloperoxidase nephritogenic autoimmunity

Joshua D. Ooi, Jhih‐Hang Jiang, Peter J. Eggenhuizen, Ling Ling Chua, Mirjan van Timmeren, Khai Lee Loh, Kim M. O’Sullivan, Poh‐Yi Gan, Yong Zhong, Kirill Tsyganov,

Nature Communications · 2019 · 54 citations · 48 references

DOIFull text

Open access

Concepts

Abstract

Abstract Autoreactivity to myeloperoxidase (MPO) causes anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), with rapidly progressive glomerulonephritis. Here, we show that a Staphylococcus aureus peptide, homologous to an immunodominant MPO T-cell epitope (MPO 409–428 ), can induce anti-MPO autoimmunity. The peptide (6PGD 391–410 ) is part of a plasmid-encoded 6-phosphogluconate dehydrogenase found in some S. aureus strains. It induces anti-MPO T-cell autoimmunity and MPO-ANCA in mice, whereas related sequences do not. Mice immunized with 6PGD 391–410 , or with S. aureus containing a plasmid expressing 6PGD 391–410 , develop glomerulonephritis when MPO is deposited in glomeruli. The peptide induces anti-MPO autoreactivity in the context of three MHC class II allomorphs. Furthermore, we show that 6PGD 391–410 is immunogenic in humans, as healthy human and AAV patient sera contain anti-6PGD and anti-6PGD 391–410 antibodies. Therefore, our results support the idea that bacterial plasmids might have a function in autoimmune disease.

References

48